Please login to the form below

Not currently logged in
Email:
Password:

hypereosinophilic syndrome

This page shows the latest hypereosinophilic syndrome news and features for those working in and with pharma, biotech and healthcare.

Nucala works in rare inflammatory disease, says GSK

Nucala works in rare inflammatory disease, says GSK

GlaxoSmithKline is eyeing another regulatory filing for its IL-5 inhibitor Nucala, after reporting positive phase 3 results with the drug in rare disease hypereosinophilic syndrome (HES).

Latest news

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....